MOS-HIV

MOS-HIV

AIDS A 45-item medical outcomes survey used for evaluating the effects of therapy on AIDS Pts
References in periodicals archive ?
The present study was conducted in conjunction with a more in-depth interview for Aboriginals and IDUs; these patients were administered the MOS-HIV first and given $10 for their participation because of the longer duration of the second interview.
We double entered the MOS-HIV questionnaires using EpiData 3.
Four of the 96 study patients were missing a total of 6 items on the MOS-HIV.
6,7) In our study, patients may have been aware of their clinical status before completing the MOS-HIV and this knowledge could have influenced patients' perceptions about their HRQL.
Last, the MOS-HIV instrument showed some psychometric weaknesses in this patient population.
The 44 items included in these subscales differ from the MOS-HIV in that they include items that are not HIV/AIDS-specific.
The MOS-HIV questionnaire (HIV-specific scales adapted from the Medical Outcomes Survey) is a widely used instrument to assess QoL.
As an example, we estimated the EQ-5D index from the MOS-HIV.
In the current analysis, patients were included if they completed both the EQ-5D and MOS-HIV at baseline.
The MOS-HIV Health Survey is a 35-item instrument measuring 10 health domains: physical function (PF), pain (PN), role function (RF), social function (SF), general health perceptions (GH), vitality (VT), cognitive function (CF), quality of life (QL), health distress (HD), and mental health (MH).
We applied an analytic scheme with 10 subscales of the MOS-HIV to examine the contribution of different predictor variables to EQ-5D index.
Table 1 presents the score distribution of the EQ-5D index and MOS-HIV subscales.